Fig. 9
From: A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
The biological functions of SHOX2 in glioma cells. A MRNA expression levels of SHOX2 were analyzed following SHOX2 siRNAs knockdown via RT-qPCR. B CCK-8 assay was used to measure cell proliferation following knockdown by SHOX2 siRNAs in U-251MG and LN-229 cells. C Wound healing assay was used to measure cell migration following knockdown by SHOX2 siRNAs in U-251MG and LN-229 cells. D Transwell assay used to measure cell invasion following knockdown by SHOX2 siRNAs in U-251MG and LN-229 cells. E Colony formation assay performed using U-251MG and LN-229 cells following knockdown via SHOX2 siRNAs. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001